Florida medical marijuana regulators ding Curaleaf with violation, Failed to recall contaminated product
On November 2, 2021, the Florida Department of Health’s Office of Medical Marijuana Use (OMMU), determined that Curaleaf Florida, LLC d/b/a Curaleaf (Curaleaf) dispensed medical marijuana products to qualified patients that reported a failed testing value of Aspergillus in violation of Rule 64ER20-9(2)(a)3., Florida Administrative Code. The contaminated products, LilacContinue Reading